Change search
Link to record
Permanent link

Direct link
Harms-Ringdahl, Mats
Publications (10 of 36) Show all publications
Amundson, S. A., Belli, M., Blettner, M., Borgmann, K., Forssell-Aronsson, E., Harms-Ringdahl, M., . . . O’Neill, P. (2025). Maintaining competence in radiation protection research: a position statement by the MELODI scientific advisory committee [Letter to the editor]. Radiation and Environmental Biophysics, 64, 201-209
Open this publication in new window or tab >>Maintaining competence in radiation protection research: a position statement by the MELODI scientific advisory committee
Show others...
2025 (English)In: Radiation and Environmental Biophysics, ISSN 0301-634X, E-ISSN 1432-2099, Vol. 64, p. 201-209Article in journal, Letter (Other (popular science, discussion, etc.)) Published
Abstract [en]

The aim of this position statement is to bring to the forefront the necessity for maintaining and enhancing high competence in assessing the impact of low dose and low dose rate exposure on human health and the urge for funding to achieve this within Europe. Exposure to low dose/dose rates of radiation can arise from multiple scenarios or events, including natural radiation exposure, the use of radiation in medicine, industry and energy production, terrorist actions and following a nuclear incident or war. Technological developments involving radiation are progressing rapidly and have the potential to benefit mankind and societal issues. The benefit of high dose exposure during radiotherapy is a well-funded area. However, the health consequences of exposure to low doses is not well understood and the area of radiation protection research (RPR) is poorly funded. High quality RPR is essential to allow updating of radiation safety regulations for optimal protection from natural, medical and occupational exposure and for assessment of radiation incidents. Continuous evaluation of risks is essential as technological developments result in new types of radiation exposure. We will overview the technologies and situations which can potentially lead to low dose exposure, evaluate what has been gained from RPR and the questions that still need addressing, discuss the current state of RPR in Europe and highlight the consequences of a failure to adequately fund this area. We conclude that increased funding for RPR is essential to maintain high competence and to allow adequate protection of the public to inevitable low dose radiation exposure.

Keywords
Environmental radiation exposure, Low dose, Low dose rate, Nuclear incident, Radiation protection, Radiation research
National Category
Radiology and Medical Imaging
Identifiers
urn:nbn:se:su:diva-242304 (URN)10.1007/s00411-025-01122-6 (DOI)001455718500001 ()40152977 (PubMedID)2-s2.0-105001507295 (Scopus ID)
Available from: 2025-04-22 Created: 2025-04-22 Last updated: 2025-09-18Bibliographically approved
Andreassi, M. G., Haddy, N., Harms-Ringdahl, M., Campolo, J., Borghini, A., Chevalier, F., . . . Haghdoost, S. (2023). A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project. International Journal of Molecular Sciences, 24(9), Article ID 8416.
Open this publication in new window or tab >>A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project
Show others...
2023 (English)In: International Journal of Molecular Sciences, ISSN 1661-6596, E-ISSN 1422-0067, Vol. 24, no 9, article id 8416Article in journal (Refereed) Published
Abstract [en]

The Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy (photon and proton) in Pediatrics (HARMONIC) is a five-year project funded by the European Commission that aimed to improve the understanding of the long-term ionizing radiation (IR) risks for pediatric patients. In this paper, we provide a detailed overview of the rationale, design, and methods for the biological aspect of the project with objectives to provide a mechanistic understanding of the molecular pathways involved in the IR response and to identify potential predictive biomarkers of individual response involved in long-term health risks. Biological samples will be collected at three time points: before the first exposure, at the end of the exposure, and one year after the exposure. The average whole-body dose, the dose to the target organ, and the dose to some important out-of-field organs will be estimated. State-of-the-art analytical methods will be used to assess the levels of a set of known biomarkers and also explore high-resolution approaches of proteomics and miRNA transcriptomes to provide an integrated assessment. By using bioinformatics and systems biology, biological pathways and novel pathways involved in the response to IR exposure will be deciphered.

Keywords
radiotherapy, ionizing radiation, proton radiotherapy, pediatric oncology, HARMONIC project, congenital heart disease, cardiac catheterization, radiation biomarkers
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:su:diva-217300 (URN)10.3390/ijms24098416 (DOI)000986236100001 ()37176123 (PubMedID)2-s2.0-85159270063 (Scopus ID)
Available from: 2023-05-24 Created: 2023-05-24 Last updated: 2024-10-15Bibliographically approved
Sangsuwan, T., Pour Khavari, A., Blomberg, E., Romell, T., D'Auria Vieira de Godoy, P. R., Harms-Ringdahl, M. & Haghdoost, S. (2023). Oxidative Stress Levels and DNA Repair Kinetics in Senescent Primary Human Fibroblasts Exposed to Chronic Low Dose Rate of Ionizing Radiation. Frontiers in Bioscience Landmark, 28(11), Article ID 296.
Open this publication in new window or tab >>Oxidative Stress Levels and DNA Repair Kinetics in Senescent Primary Human Fibroblasts Exposed to Chronic Low Dose Rate of Ionizing Radiation
Show others...
2023 (English)In: Frontiers in Bioscience Landmark, ISSN 2768-6701, Vol. 28, no 11, article id 296Article in journal (Refereed) Published
Abstract [en]

Background: Exposure to low dose rate (LDR) radiation may accelerate aging processes. Previously, we identified numerous LDR-induced pathways involved in oxidative stress (OS) and antioxidant systems, suggesting that these pathways protect against premature senescence (PS). This study aimed to investigate if there are differences between young replicative senescent (RS) and PS cells considering DNA repair kinetics, OS, and DNA damage localized in the telomeres. Methods: We established PS cells by culturing and passaging young primary fibroblasts exposed to LDR. Then, RS cells were established by culturing and passaging young fibroblasts until they stopped proliferating. Senescence was characterized by analyzing telomere length and senescence-associated β-galactosidase (SA-β-gal) staining. DNA damage and repair were evaluated with γH2AX foci formation; telomere identification was carried out using the fluorescence in situ hybridization (FISH) probe; and oxidative stress was assessed by measuring 8-oxo-dG in the medium. Results: The data indicate the following: young cells have a better ability to cope with LDR-induced oxidative stress; RS and PS have higher steady-state levels of DNA damage; RS have slower DNA repair kinetics; and PS/RS have elevated levels of telomeric DNA damage. Conclusion: Our main conclusion is that PS and RS differ regarding DNA repair kinetics and SA-β-gal levels.

Keywords
radiation, chronic radiation, low dose rate, premature senescence, replicative senescence, DNA repair, radiotherapy, oxidative stress, hMTH1, telomere length, extracellular 8-oxo-dG
National Category
Cell Biology Biochemistry Molecular Biology
Identifiers
urn:nbn:se:su:diva-225663 (URN)10.31083/j.fbl2811296 (DOI)001124039900011 ()38062840 (PubMedID)2-s2.0-85179638332 (Scopus ID)
Available from: 2024-01-22 Created: 2024-01-22 Last updated: 2025-02-20Bibliographically approved
Babini, G., Baiocco, G., Barbieri, S., Morini, J., Sangsuwan, T., Haghdoost, S., . . . Ottolenghi, A. (2022). A systems radiation biology approach to unravel the role of chronic low-dose-rate gamma-irradiation in inducing premature senescence in endothelial cells. PLOS ONE, 17(3), Article ID e0265281.
Open this publication in new window or tab >>A systems radiation biology approach to unravel the role of chronic low-dose-rate gamma-irradiation in inducing premature senescence in endothelial cells
Show others...
2022 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 17, no 3, article id e0265281Article in journal (Refereed) Published
Abstract [en]

Purpose

The aim of this study was to explore the effects of chronic low-dose-rate gamma-radiation at a multi-scale level. The specific objective was to obtain an overall view of the endothelial cell response, by integrating previously published data on different cellular endpoints and highlighting possible different mechanisms underpinning radiation-induced senescence.

Materials and methods

Different datasets were collected regarding experiments on human umbilical vein endothelial cells (HUVECs) which were chronically exposed to low dose rates (0, 1.4, 2.1 and 4.1 mGy/h) of gamma-rays until cell replication was arrested. Such exposed cells were analyzed for different complementary endpoints at distinct time points (up to several weeks), investigating cellular functions such as proliferation, senescence and angiogenic properties, as well as using transcriptomics and proteomics profiling. A mathematical model was proposed to describe proliferation and senescence.

Results

Simultaneous ceasing of cell proliferation and senescence onset as a function of time were well reproduced by the logistic growth curve, conveying shared equilibria between the two endpoints. The combination of all the different endpoints investigated highlighted a dose-dependence for prematurely induced senescence. However, the underpinning molecular mechanisms appeared to be dissimilar for the different dose rates, thus suggesting a more complex scenario.

Conclusions

This study was conducted integrating different datasets, focusing on their temporal dynamics, and using a systems biology approach. Results of our analysis highlight that different dose rates have different effects in inducing premature senescence, and that the total cumulative absorbed dose also plays an important role in accelerating endothelial cell senescence.

National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:su:diva-204920 (URN)10.1371/journal.pone.0265281 (DOI)000799880200013 ()35286349 (PubMedID)2-s2.0-85126678294 (Scopus ID)
Available from: 2022-05-25 Created: 2022-05-25 Last updated: 2022-06-29Bibliographically approved
Drobin, K., Marczyk, M., Halle, M., Danielsson, D., Papiez, A., Sangsuwan, T., . . . Haghdoost, S. (2020). Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. Cancers, 12(3), Article ID 753.
Open this publication in new window or tab >>Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer
Show others...
2020 (English)In: Cancers, ISSN 2072-6694, Vol. 12, no 3, article id 753Article in journal (Refereed) Published
Abstract [en]

Nearly half of all cancers are treated with radiotherapy alone or in combination with other treatments, where damage to normal tissues is a limiting factor for the treatment. Radiotherapy-induced adverse health effects, mostly of importance for cancer patients with long-term survival, may appear during or long time after finishing radiotherapy and depending on the patient's radiosensitivity. Currently, there is no assay available that can reliably predict the individual's response to radiotherapy. We profiled two study sets from breast (n = 29) and head-and-neck cancer patients (n = 74) that included radiosensitive patients and matched radioresistant controls. We studied 55 single nucleotide polymorphisms (SNPs) in 33 genes by DNA genotyping and 130 circulating proteins by affinity-based plasma proteomics. In both study sets, we discovered several plasma proteins with the predictive power to find radiosensitive patients (adjusted p < 0.05) and validated the two most predictive proteins (THPO and STIM1) by sandwich immunoassays. By integrating genotypic and proteomic data into an analysis model, it was found that the proteins CHIT1, PDGFB, PNKD, RP2, SERPINC1, SLC4A, STIM1, and THPO, as well as the VEGFA gene variant rs69947, predicted radiosensitivity of our breast cancer (AUC = 0.76) and head-and-neck cancer (AUC = 0.89) patients. In conclusion, circulating proteins and a SNP variant of VEGFA suggest that processes such as vascular growth capacity, immune response, DNA repair and oxidative stress/hypoxia may be involved in an individual's risk of experiencing radiation-induced toxicity.

Keywords
radiosensitivity, prediction, plasma proteins, radiotherapy, breast cancer, head-and-neck cancer, skin reaction, biomarker, mandibular osteoradionecrosis, ionizing radiation, radiotherapy side effects, personalized radiotherapy
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:su:diva-182911 (URN)10.3390/cancers12030753 (DOI)000530232300229 ()32235817 (PubMedID)
Available from: 2020-06-25 Created: 2020-06-25 Last updated: 2022-03-23Bibliographically approved
Wojcik, A. & Harms-Ringdahl, M. (2019). Radiation protection biology then and now. International Journal of Radiation Biology, 95(7), 841-850
Open this publication in new window or tab >>Radiation protection biology then and now
2019 (English)In: International Journal of Radiation Biology, ISSN 0955-3002, E-ISSN 1362-3095, Vol. 95, no 7, p. 841-850Article, review/survey (Refereed) Published
Abstract [en]

Purpose: Radiation biology is a branch of the radiation research field which focuses on studying radiation effects in cells and organisms. Radiation can be used in biological investigations for two, mutually non-exclusive reasons: (1) to study biological processes by perturbing their functioning (qualitative approach) and (2) to assess consequences of radiation-induced damage (quantitative approach). While the former approach has a basic research character, the latter has an applied character that is driven by needs of medical applications and radiological protection. Radiation protection biology is defined in the sense of the second approach. The aim of the article is to provide a historical review of how radiation protection biology developed and how it influences radiological protection.Conclusions: While radiobiological investigations started immediately after the discovery of X-rays, the qualitative approach dominated until the end of World War II. After 1945, the nuclear weapons race and nuclear energy programs initiated quantitative radiobiological research. Radiation protection biology does not provide results from which radiation risks can be directly derived. Rather, it provides data that is necessary for understanding the nature of risks. Most recent years have seen, especially in Europe, a growing interest in coordinated studies on the effects of low radiation doses.

Keywords
Radiation biology, radiation research, history, radiological protection, low-dose program
National Category
Biological Sciences
Identifiers
urn:nbn:se:su:diva-171768 (URN)10.1080/09553002.2019.1589027 (DOI)000475933600004 ()30831044 (PubMedID)
Available from: 2019-08-28 Created: 2019-08-28 Last updated: 2022-03-23Bibliographically approved
Kreuzer, M., Auvinen, A., Cardis, E., Durante, M., Harms-Ringdahl, M., Jourdain, J. R., . . . Bouffler, S. (2018). Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research. Radiation and Environmental Biophysics, 57(1), 5-15
Open this publication in new window or tab >>Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research
Show others...
2018 (English)In: Radiation and Environmental Biophysics, ISSN 0301-634X, E-ISSN 1432-2099, Vol. 57, no 1, p. 5-15Article, review/survey (Refereed) Published
Abstract [en]

MELODI (Multidisciplinary European Low Dose Initiative) is a European radiation protection research platform with focus on research on health risks after exposure to low-dose ionising radiation. It was founded in 2010 and currently includes 44 members from 18 countries. A major activity of MELODI is the continuous development of a long-term European Strategic Research Agenda (SRA) on low-dose risk for radiation protection. The SRA is intended to identify priorities for national and European radiation protection research programs as a basis for the preparation of competitive calls at the European level. Among those key priorities is the improvement of health risk estimates for exposures close to the dose limits for workers and to reference levels for the population in emergency situations. Another activity of MELODI is to ensure the availability of European key infrastructures for research activities, and the long-term maintenance of competences in radiation research via an integrated European approach for training and education. The MELODI SRA identifies three key research topics in low dose or low dose-rate radiation risk research: (1) dose and dose rate dependence of cancer risk, (2) radiation-induced non-cancer effects and (3) individual radiation sensitivity. The research required to improve the evidence base for each of the three key topics relates to three research lines: (1) research to improve understanding of the mechanisms contributing to radiogenic diseases, (2) epidemiological research to improve health risk evaluation of radiation exposure and (3) research to address the effects and risks associated with internal exposures, differing radiation qualities and inhomogeneous exposures. The full SRA and associated documents can be downloaded from the MELODI website (http://www.melodi-online.eu/sra.html).

Keywords
Low-dose, Health effects, Cancer, Non-cancer, Individual sensitivity, Ionizing radiation
National Category
Biological Sciences Earth and Related Environmental Sciences Cancer and Oncology
Identifiers
urn:nbn:se:su:diva-153595 (URN)10.1007/s00411-017-0726-1 (DOI)000425287100002 ()29247291 (PubMedID)
Available from: 2018-03-15 Created: 2018-03-15 Last updated: 2025-01-31Bibliographically approved
McLean, A. R., Adlen, E. K., Cardis, E., Elliott, A., Goodhead, D. T., Harms-Ringdahl, M., . . . Godfray, H. C. (2017). A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation. Proceedings of the Royal Society of London. Biological Sciences, 284(1862), Article ID 20171070.
Open this publication in new window or tab >>A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation
Show others...
2017 (English)In: Proceedings of the Royal Society of London. Biological Sciences, ISSN 0962-8452, E-ISSN 1471-2954, Vol. 284, no 1862, article id 20171070Article, review/survey (Refereed) Published
Abstract [en]

Exposure to ionizing radiation is ubiquitous, and it is well established that moderate and high doses cause ill-health and can be lethal. The health effects of low doses or low dose-rates of ionizing radiation are not so clear. This paper describes a project which sets out to summarize, as a restatement, the natural science evidence base concerning the human health effects of exposure to low-level ionizing radiation. A novel feature, compared to other reviews, is that a series of statements are listed and categorized according to the nature and strength of the evidence that underpins them. The purpose of this restatement is to provide a concise entree into this vibrant field, pointing the interested reader deeper into the literature when more detail is needed. It is not our purpose to reach conclusions on whether the legal limits on radiation exposures are too high, too low or just right. Our aim is to provide an introduction so that non-specialist individuals in this area (be they policy-makers, disputers of policy, health professionals or students) have a straightforward place to start. The summary restatement of the evidence and an extensively annotated bibliography are provided as appendices in the electronic supplementary material.

Keywords
radiation, epidemiology, cancer, radon, nuclear, evidence for policy
National Category
Biological Sciences
Identifiers
urn:nbn:se:su:diva-180157 (URN)10.1098/rspb.2017.1070 (DOI)000410610200013 ()28904138 (PubMedID)
Available from: 2020-03-24 Created: 2020-03-24 Last updated: 2022-03-23Bibliographically approved
Hall, J., Jeggo, P. A., West, C., Gomolka, M., Quintens, R., Badie, C., . . . Cardis, E. (2017). Ionizing radiation biomarkers in epidemiological studies - An update. Mutation Research, 771, 59-84
Open this publication in new window or tab >>Ionizing radiation biomarkers in epidemiological studies - An update
Show others...
2017 (English)In: Mutation Research, ISSN 1383-5742, E-ISSN 1388-2139, Vol. 771, p. 59-84Article, review/survey (Refereed) Published
Abstract [en]

Recent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of < 100 mSv and dose rates of < 10 mGy per year; paediatric patients studies have reported increased leukaemia and brain tumours risks after doses of 30-60 mGy from computed tomography scans. Questions arise, however, about the impact of even lower doses and dose rates where classical epidemiological studies have limited power but where subsets within the large cohorts are expected to have an increased risk. Further progress requires integration of biomarkers or bioassays of individual exposure, effects and susceptibility to IR. The European DoReMi (Low Dose Research towards Multidisciplinary Integration) consortium previously reviewed biomarkers for potential use in IR epidemiological studies. Given the increased mechanistic understanding of responses to low dose radiation the current review provides an update covering technical advances and recent studies. A key issue identified is deciding which biomarkers to progress. A roadmap is provided for biomarker development from discovery to implementation and used to summarise the current status of proposed biomarkers for epidemiological studies. Most potential biomarkers remain at the discovery stage and for some there is sufficient evidence that further development is not warranted. One biomarker identified in the final stages of development and as a priority for further research is radiation specific mRNA transcript profiles.

Keywords
Molecular epidemiology, Biomarkers, Ionizing radiation, Effects, Exposure, Individual sensitivity
National Category
Biological Sciences
Identifiers
urn:nbn:se:su:diva-143856 (URN)10.1016/j.mrrev.2017.01.001 (DOI)000399850400004 ()28342453 (PubMedID)
Available from: 2017-06-05 Created: 2017-06-05 Last updated: 2022-02-28Bibliographically approved
Hauptmann, M., Haghdoost, S., Gomolka, M., Sarioglu, H., Ueffing, M., Dietz, A., . . . Hornhardt, S. (2016). Differential Response and Priming Dose Effect on the Proteome of Human Fibroblast and Stem Cells Induced by Exposure to Low Doses of Ionizing Radiation. Radiation Research, 185(3), 299-312
Open this publication in new window or tab >>Differential Response and Priming Dose Effect on the Proteome of Human Fibroblast and Stem Cells Induced by Exposure to Low Doses of Ionizing Radiation
Show others...
2016 (English)In: Radiation Research, ISSN 0033-7587, E-ISSN 1938-5404, Vol. 185, no 3, p. 299-312Article in journal (Refereed) Published
Abstract [en]

It has been suggested that a mechanistic understanding of the cellular responses to low dose and dose rate may be valuable in reducing some of the uncertainties involved in current risk estimates for cancer- and non-cancer-related radiation effects that are inherited in the linear nothreshold hypothesis. In this study, the effects of low-dose radiation on the proteome in both human fibroblasts and stem cells were investigated. Particular emphasis was placed on examining: 1. the dose-response relationships for the differential expression of proteins in the low-dose range (40-140 mGy) of low-linear energy transfer (LET) radiation; and 2. the effect on differential expression of proteins of a priming dose given prior to a challenge dose (adaptive response effects). These studies were performed on cultured human fibroblasts (VH10) and human adipose-derived stem cells (ADSC). The results from the VH10 cell experiments demonstrated that low-doses of low-LET radiation induced unique patterns of differentially expressed proteins for each dose investigated. In addition, a low priming radiation dose significantly changed the protein expression induced by the subsequent challenge exposure. In the ADSC the number of differentially expressed proteins was markedly less compared to VH10 cells, indicating that ADSC differ in their intrinsic response to low doses of radiation. The proteomic results are further discussed in terms of possible pathways influenced by low-dose irradiation.

National Category
Biological Sciences Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:su:diva-132013 (URN)10.1667/RR14226.1 (DOI)000376754000008 ()26934482 (PubMedID)
Available from: 2016-08-09 Created: 2016-07-05 Last updated: 2022-02-23Bibliographically approved
Organisations

Search in DiVA

Show all publications